ZYNE — Zynerba Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI
Zynerba surges on buyout by Harmony Biosciences
Zynerba surges on buyout by Harmony Biosciences
Brief: Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals Inc expected to post a loss of 20 cents a share - Earnings Preview
Zynerba Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Zynerba Pharmaceuticals Inc Intends To Seek Approval Of Reverse Stock Split At Annual Meeting
Brief: Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results
Zynerba Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Zynerba Pharmaceuticals - On May 2 Nasdaq Notified Co It Granted Co Additional 180 Calendar Day Period To Regain Compliance With Bid Price Rule
Brief: Zynerba Pharmaceuticals Presents Data On Zygel At The 55Th Gatlinburg Conference
Zynerba Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Zynerba Pharmaceuticals Confirms Not Holding Cash Deposits Or Securities At Silicon Valley Bank
Brief: Zynerba Pharmaceuticals Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank